RecruitingEarly Phase 1NCT06584786

Therapeutic Effects of Jing Si Herbal Tea for COPD

Therapeutic Effects of Jing Si Herbal Tea for Chronic Obstructive Pulmonary Disease: A Comprehensive Investigation From Clinical to Basic Research

Sponsor

Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation

Enrollment

120 participants

Start Date

Jan 1, 2022

Study Type

INTERVENTIONAL

Conditions

Airway Disease

Summary

Chronic obstructive pulmonary disease (COPD), a leading cause of global mortality, significantly impairs health-related quality of life (HRQL). COPD is characterized by airway inflammation and lung tissue damage. Jing Si herbal tea (JSHT) is known to have anti-inflammatory effects but has not been explored for treating COPD. This study investigated the potential of JSHT as an adjuvant therapy for COPD. This randomized controlled study focused on patients with COPD in the exacerbation and stable phases. The control group received the standard treatment, and the JSHT group received the standard treatment plus JSHT. Both groups underwent HRQL assessments, blood tests, and cellular studies involving five different groups to assess the effect of JSHT on damage-associated molecular patterns (DAMPs) and inflammatory markers.

Eligibility

Min Age: 20 Years

Plain Language Summary

Simplified for easier understanding

This study is testing Jing Si Herbal Tea — a traditional Chinese herbal drink — as a potential treatment to reduce symptoms and improve quality of life in people with chronic obstructive pulmonary disease (COPD), a long-term lung condition that causes breathing difficulties. **You may be eligible if...** - You have been diagnosed with COPD - You are willing to participate in the study **You may NOT be eligible if...** - You do not have COPD - You are not willing to participate in the study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.